Neutrophil-mediated trogocytosis as a new mechanism of action of daratumumab.

Blood Neoplasia · 2025 · PMC12483589 · PMID 41036484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

NCI-H929-CD38 cells achieved significantly higher levels of trogocytosis in the presence of daratumumab as compared to the parental NCI-H929 cell line and NCI-H929 cells transduced with the empty vector (NCI-H929-EV), however, cell death percentage did not reach statistical significance ( Figure 1 H).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.